InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the detailed record of transactions filed by Thomas Jonassen. Director active across 1 company, notably SynAct Pharma AB. Cumulatively, 5 reports have been published. History available since 6 January 2021. The latest transaction was filed on 2 September 2026 (Sale). Regulator: FIN-FSA. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条